dacarbazine and Ependymoma

dacarbazine has been researched along with Ependymoma in 17 studies

Research

Studies (17)

TimeframeStudies, this research(%)All Research%
pre-19902 (11.76)18.7374
1990's1 (5.88)18.2507
2000's5 (29.41)29.6817
2010's8 (47.06)24.3611
2020's1 (5.88)2.80

Authors

AuthorsStudies
Benvenuto, J; Farquhar, D1
Aldape, K; Armstrong, TS; Gerstner, ER; Gilbert, MR; Lieberman, F; Mendoza, T; Mikkelsen, T; Omuro, A; Robins, HI; Vera, E; Wen, PY; Wu, J; Yuan, Y1
Bellu, L; Della Puppa, A; Gardiman, MP; Lombardi, G; Pambuku, A; Pomerri, F; Rumanò, L; Zagonel, V1
Arena, V; Binda, E; Lamorte, G; Meco, D; Riccardi, R; Servidei, T1
Fujihara, I; Fukuoka, K; Ichimura, K; Komori, K; Miyairi, Y; Morita, D; Nakamura, T; Ogiso, Y; Sakashita, K; Sano, K; Shigeta, H; Shiohara, M; Shirahata, M; Yanagisawa, R1
Bosa, C; Cassoni, P; Fiano, V; Franchino, F; Magistrello, M; Pellerino, A; Rudà, R; Soffietti, R; Trevisan, M1
Felsberg, J; Gramatzki, D; Hentschel, B; Hofer, S; Krex, D; Reifenberger, G; Roth, P; Rushing, EJ; Schnell, O; Simon, M; Weller, M; Westphal, M; Wick, W1
Chamberlain, MC; Johnston, SK1
Freyschlag, CF; Lohr, F; Schmieder, K; Seiz, M; Thomé, C; Tuettenberg, J1
Salameire, D1
Goto, Y; Hashimoto, N; Kagawa, N; Khoo, HM; Kinoshita, M; Kishima, H; Maruno, M; Yoshimine, T1
Baayen, HC; Barkhof, F; Boogerd, W; Castelijns, JA; Elkhuizen, PH; Heimans, JJ; Postma, TJ; Uitdehaag, BM; Vos, MJ1
Calvet, D; Delattre, JY; Janoray, P; Rojas-Marcos, I1
Brock, C; Newlands, ES; Rehman, S1
Bernstein, M; Fort, D; Friedman, H; Harris, MB; Kadota, R; Krailo, M; Kretschmar, CS; Mazewski, C; Nicholson, HS; Reaman, GH; Sato, J; Tedeschi-Blok, N1
Beal, DD; Bryan, GT; Cohen, SM; Croft, WA; Skibba, JL1
Bruce-Gregorios, JH; Feun, LG; Green, B; Nadeem, SQ1

Trials

2 trial(s) available for dacarbazine and Ependymoma

ArticleYear
A phase II study of dose-dense temozolomide and lapatinib for recurrent low-grade and anaplastic supratentorial, infratentorial, and spinal cord ependymoma.
    Neuro-oncology, 2021, 03-25, Volume: 23, Issue:3

    Topics: Adolescent; Adult; Brain Neoplasms; Dacarbazine; Disease-Free Survival; Ependymoma; Humans; Lapatinib; Prospective Studies; Spinal Cord Neoplasms; Temozolomide

2021
Phase 2 study of temozolomide in children and adolescents with recurrent central nervous system tumors: a report from the Children's Oncology Group.
    Cancer, 2007, Oct-01, Volume: 110, Issue:7

    Topics: Administration, Oral; Adolescent; Adult; Antineoplastic Agents, Alkylating; Astrocytoma; Brain Neoplasms; Central Nervous System Neoplasms; Child; Child, Preschool; Dacarbazine; Drug Administration Schedule; Ependymoma; Female; Humans; Infant; Male; Medulloblastoma; Neoplasm Recurrence, Local; Neuroectodermal Tumors, Primitive; Temozolomide; Treatment Outcome

2007

Other Studies

15 other study(ies) available for dacarbazine and Ependymoma

ArticleYear
1-Aryl-3,3-dimethyltriazenes: potential central nervous system active analogues of 5-(3,3-dimethyl-1-triazeno)imidazole-4-carboxamide (DTIC).
    Journal of medicinal chemistry, 1984, Volume: 27, Issue:12

    Topics: Animals; Antineoplastic Agents; Blood-Brain Barrier; Brain Neoplasms; Dacarbazine; Drug Evaluation, Preclinical; Ependymoma; Leukemia L1210; Melanoma; Mice; Mice, Inbred Strains; Structure-Activity Relationship

1984
Cisplatin and temozolomide combination in the treatment of supratentorial anaplastic ependymoma.
    Chemotherapy, 2013, Volume: 59, Issue:3

    Topics: Antineoplastic Agents; Brain Neoplasms; Cisplatin; Dacarbazine; Drug Therapy, Combination; Ependymoma; Female; Humans; Magnetic Resonance Imaging; Middle Aged; Radiography; Temozolomide; Treatment Outcome

2013
Ependymoma stem cells are highly sensitive to temozolomide in vitro and in orthotopic models.
    Neuro-oncology, 2014, Volume: 16, Issue:8

    Topics: Animals; Antineoplastic Agents, Alkylating; Dacarbazine; Disease Models, Animal; DNA Modification Methylases; Drug Resistance, Neoplasm; Ependymoma; Glioblastoma; Mice, Nude; O(6)-Methylguanine-DNA Methyltransferase; Stem Cells; Temozolomide; Tumor Cells, Cultured; Tumor Suppressor Protein p53; Xenograft Model Antitumor Assays

2014
Temozolomide Treatment for Pediatric Refractory Anaplastic Ependymoma with Low MGMT Protein Expression.
    Pediatric blood & cancer, 2016, Volume: 63, Issue:1

    Topics: Antineoplastic Agents, Alkylating; Brain Neoplasms; Child, Preschool; Dacarbazine; DNA Modification Methylases; DNA Repair Enzymes; Ependymoma; Female; Humans; Immunohistochemistry; Infant; Male; Temozolomide; Tumor Suppressor Proteins

2016
Temozolomide as salvage treatment for recurrent intracranial ependymomas of the adult: a retrospective study.
    Neuro-oncology, 2016, Volume: 18, Issue:2

    Topics: Adolescent; Adult; Antineoplastic Agents, Alkylating; Brain Neoplasms; Dacarbazine; Ependymoma; Female; Follow-Up Studies; Humans; Male; Middle Aged; Neoplasm Grading; Neoplasm Recurrence, Local; Prognosis; Retrospective Studies; Salvage Therapy; Survival Rate; Temozolomide; Young Adult

2016
Chemotherapy for intracranial ependymoma in adults.
    BMC cancer, 2016, Apr-23, Volume: 16

    Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Brain Neoplasms; Dacarbazine; Disease-Free Survival; Ependymoma; Epirubicin; Female; Humans; Ifosfamide; Kaplan-Meier Estimate; Lomustine; Male; Middle Aged; Procarbazine; Temozolomide; Treatment Outcome; Vincristine

2016
Temozolomide for recurrent intracranial supratentorial platinum-refractory ependymoma.
    Cancer, 2009, Oct-15, Volume: 115, Issue:20

    Topics: Adult; Antineoplastic Agents, Alkylating; Carboplatin; Cisplatin; Dacarbazine; Disease-Free Survival; Drug Resistance, Neoplasm; Ependymoma; Female; Ferrous Compounds; Humans; Male; Metallocenes; Middle Aged; Neoplasm Recurrence, Local; Retreatment; Supratentorial Neoplasms; Temozolomide

2009
Response to temozolomide in supratentorial multifocal recurrence of malignant ependymoma.
    Anticancer research, 2011, Volume: 31, Issue:3

    Topics: Adult; Antineoplastic Agents; Brain Neoplasms; Dacarbazine; Disease Progression; Ependymoma; Female; Follow-Up Studies; Humans; Magnetic Resonance Imaging; Recurrence; Supratentorial Neoplasms; Temozolomide; Treatment Outcome

2011
[Cutaneous neutrophils infiltrates. Case 4. Pseudo-tumoral cutaneous alternariosis].
    Annales de pathologie, 2011, Volume: 31, Issue:3

    Topics: Aged, 80 and over; Alternaria; Antifungal Agents; Antineoplastic Agents, Alkylating; Brain Neoplasms; Carcinoma, Verrucous; Combined Modality Therapy; Dacarbazine; Dermatomycoses; Diagnosis, Differential; Ependymoma; Fatal Outcome; Folliculitis; Frontal Lobe; Hand Dermatoses; Humans; Immunocompromised Host; Keratosis; Male; Neutrophils; Pyrimidines; Skin Neoplasms; Staining and Labeling; Temozolomide; Triazoles; Voriconazole

2011
Radiation-induced anaplastic ependymoma with a remarkable clinical response to temozolomide: a case report.
    British journal of neurosurgery, 2013, Volume: 27, Issue:2

    Topics: Adult; Antineoplastic Agents, Alkylating; Astrocytoma; Cerebellar Neoplasms; Dacarbazine; Ependymoma; Female; Humans; Neoplasms, Radiation-Induced; Neoplasms, Second Primary; Temozolomide

2013
Interobserver variability in the radiological assessment of response to chemotherapy in glioma.
    Neurology, 2003, Mar-11, Volume: 60, Issue:5

    Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Astrocytoma; Brain Neoplasms; Carboplatin; Dacarbazine; Ependymoma; Female; Glioblastoma; Glioma; Humans; Image Enhancement; Lomustine; Magnetic Resonance Imaging; Male; Middle Aged; Neoplasm Recurrence, Local; Observer Variation; Oligodendroglioma; Paclitaxel; Procarbazine; Sensitivity and Specificity; Temozolomide; Tomography, X-Ray Computed; Treatment Outcome; Vincristine

2003
Response of recurrent anaplastic ependymoma to a combination of tamoxifen and isotretinoin.
    Neurology, 2003, Oct-14, Volume: 61, Issue:7

    Topics: Adrenal Cortex Hormones; Adult; Antineoplastic Combined Chemotherapy Protocols; Brain; Brain Neoplasms; Carboplatin; Carmustine; Dacarbazine; Disease Progression; Dose Fractionation, Radiation; Ependymoma; Gadolinium; Headache; Humans; Isotretinoin; Magnetic Resonance Imaging; Male; Neoplasm Recurrence, Local; Remission Induction; Tamoxifen; Temozolomide; Tomography, X-Ray Computed; Treatment Outcome

2003
A case report of a recurrent intracranial ependymoma treated with temozolomide in remission 10 years after completing chemotherapy.
    American journal of clinical oncology, 2006, Volume: 29, Issue:1

    Topics: Adult; Antineoplastic Agents, Alkylating; Brain Neoplasms; Dacarbazine; Ependymoma; Female; Humans; Neoplasm Recurrence, Local; Temozolomide; Time Factors

2006
Carcinogenicity of the antineoplastic agent, 5-(3,3-dimethyl-1-triazeno)-imidazole-4-carboxamide, and its metabolites in rats.
    Journal of the National Cancer Institute, 1975, Volume: 54, Issue:4

    Topics: Adenofibroma; Administration, Oral; Animals; Aza Compounds; Carcinogens; Dacarbazine; Dose-Response Relationship, Drug; Ependymoma; Female; Hypoxanthines; Injections, Intraperitoneal; Intubation, Gastrointestinal; Leiomyosarcoma; Male; Mammary Neoplasms, Experimental; Neoplasms, Experimental; Organ Specificity; Rats; Stomach Neoplasms; Thymus Neoplasms; Time Factors; Triazenes; Urinary Bladder Neoplasms; Uterine Neoplasms

1975
Post radiation sarcoma (malignant fibrous histiocytoma) of the cervical spine following ependymoma (a case report).
    Journal of neuro-oncology, 1991, Volume: 11, Issue:3

    Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Astrocytoma; Cervical Vertebrae; Combined Modality Therapy; Dacarbazine; Dexamethasone; Diagnostic Errors; Doxorubicin; Ependymoma; Histiocytoma, Benign Fibrous; Humans; Laminectomy; Male; Neoplasms, Radiation-Induced; Neoplasms, Second Primary; Radiotherapy, High-Energy; Spinal Cord Neoplasms; Spinal Neoplasms

1991